- BullsNBears.com, Inc. (BNBI)Posted 7 years ago
- Guardian 8 Holdings (GRDH)Posted 7 years ago
- OmniBio Pharmaceutical, Inc. (OMBP)Posted 7 years ago
- Native American Energy Group, Inc. (NAGP)Posted 7 years ago
- Retrophin, Inc. (RTRX)Posted 7 years ago
Retrophin, Inc. (RTRX)
Retrophin, Inc. (OTCQB: RTRX) is a publicly-traded New York-based biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases. Retrophin is currently developing treatments for Focal Segmental Glomerulosclerosis (FSGS), Pantothenate Kinase-Associated Neurodegeneration (PKAN), Duchenne Muscular Dystrophy and other catastrophic diseases.
Company Data
Industry: BioTech
IR Contact: Martin Shkreli CEO
IR Email: [email protected]
Phone: (212) 983-1310
Address: Retrophin, Inc.
777 Third Avenue, 22nd Floor
New York, NY 10017
Fiscal Year End: December, 31st
Executives: Martin Shkreli – President and CEO
Online Resources
Company Website:
Stock Information:
Company Fillings
Company Presentation
http://retrophin.com/retrophin/News/Retrophin%20Feb%2012%202013%20Presentation
){kind=link}
You must be logged in to post a comment Login